Search results
Results from the WOW.Com Content Network
4,6-Dimethyldibenzothiophene is an organosulfur compound with the formula (C 6 H 3 CH 3) 2 S. It is one of several dimethyl derivatives of benzothiophene. The compound is of particular interest as an organosulfur contaminant in petroleum that is recalcitrant. Both methyl groups shield the sulfur center from desulfurization.
3,4-Methylenedioxyamphetamine. 3,4-Methylenedioxyamphetamine (also known as MDA and sass) is an empathogen-entactogen, psychostimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug. In its pharmacology, MDA is a serotonin–norepinephrine–dopamine releasing agent (SNDRA).
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
3,4- Di methoxy phenethylamine ( DMPEA) is a chemical compound of the phenethylamine class. It is an analogue of the major human neurotransmitter dopamine where the 3- and 4-position hydroxy groups have been replaced with methoxy groups. It is also closely related to mescaline which is 3,4,5-trimethoxyphenethylamine.
Benzylideneacetone is the organic compound described by the formula C 6 H 5 CH=CHC (O)CH 3. Although both cis - and trans -isomers are possible for the α,β-unsaturated ketone, only the trans isomer is observed. Its original preparation demonstrated the scope of condensation reactions to construct new, complex organic compounds. [1]
Heptene is a higher olefin, or alkene with the formula C 7 H 14 . The commercial product is a liquid that is a mixture of isomers. It is used as an additive in lubricants, as a catalyst, and as a surfactant. This chemical is also known as heptylene. A log-lin vapor pressure chart of Heptene compared with various liquids.
3,4-Methylenedioxycathinone (also known as MDC, Nitrilone, Amylone and βk-MDA) is an empathogen and stimulant of the phenethylamine, amphetamine, and cathinone classes [1] [2] and the β-keto analogue of MDA. [3] Methylenedioxycathinone has been investigated as antidepressant and antiparkinson agent. [4]
Gedatolisib ( PF-05212384) is an experimental drug for treatment of cancer in development by Celcuity, Inc. The mechanism of action is accomplished by binding the different p110 catalytic subunit isoforms of PI3K and the kinase site of mTOR. [1] The drug was originally developed by Wyeth, which Pfizer acquired in 2009.